NORTHERN TRUST CORP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$29,552,461
-20.2%
588,460
+0.5%
0.01%
-14.3%
Q2 2023$37,016,050
+42.4%
585,697
+1.4%
0.01%
+40.0%
Q1 2023$25,987,394
+6.3%
577,626
+3.5%
0.01%0.0%
Q4 2022$24,441,073
-33.1%
557,888
+0.6%
0.01%
-37.5%
Q3 2022$36,559,000
+30.1%
554,833
-0.3%
0.01%
+33.3%
Q2 2022$28,107,000
-24.1%
556,462
-4.0%
0.01%
-14.3%
Q1 2022$37,047,000
-49.6%
579,947
-15.4%
0.01%
-41.7%
Q4 2021$73,442,000
+1.2%
685,669
-2.8%
0.01%
-7.7%
Q3 2021$72,541,000
+15.2%
705,572
-1.5%
0.01%
+18.2%
Q2 2021$62,976,000
+0.4%
715,960
+11.0%
0.01%
-8.3%
Q1 2021$62,740,000
-18.7%
645,260
-6.2%
0.01%
-20.0%
Q4 2020$77,184,000
+17.9%
688,215
-2.6%
0.02%
+7.1%
Q3 2020$65,476,000
+13.7%
706,324
-4.3%
0.01%0.0%
Q2 2020$57,574,000
+41.2%
738,134
+5.9%
0.01%
+16.7%
Q1 2020$40,775,000
-20.1%
697,249
+9.5%
0.01%
+9.1%
Q4 2019$51,024,000
+7.5%
636,936
-1.4%
0.01%0.0%
Q3 2019$47,466,000
-15.8%
646,068
+8.2%
0.01%
-15.4%
Q2 2019$56,349,000
+34.9%
597,366
+14.5%
0.01%
+30.0%
Q1 2019$41,778,000
+53.7%
521,896
+3.5%
0.01%
+25.0%
Q4 2018$27,190,000
-33.1%
504,348
-3.2%
0.01%
-20.0%
Q3 2018$40,659,000
+28.1%
520,856
+4.2%
0.01%
+25.0%
Q2 2018$31,735,000
-30.4%
499,911
+0.6%
0.01%
-33.3%
Q1 2018$45,588,000
+21.8%
497,135
+0.1%
0.01%
+33.3%
Q4 2017$37,434,000
+15.0%
496,409
+6.3%
0.01%
+12.5%
Q3 2017$32,546,000
+35.6%
467,142
-1.4%
0.01%
+14.3%
Q2 2017$23,995,000
+95.8%
473,545
+54.5%
0.01%
+75.0%
Q1 2017$12,257,000
+78.7%
306,501
+25.4%
0.00%
+100.0%
Q4 2016$6,858,000
-2.7%
244,493
+3.0%
0.00%0.0%
Q3 2016$7,050,000
+63.2%
237,367
+11.3%
0.00%
+100.0%
Q2 2016$4,320,000
+112.2%
213,313
+89.1%
0.00%0.0%
Q1 2016$2,036,000
-30.1%
112,789
+2.0%
0.00%0.0%
Q4 2015$2,912,000
+28.3%
110,542
+4.0%
0.00%0.0%
Q3 2015$2,269,000
+205.0%
106,315
+278.8%
0.00%
Q2 2015$744,00028,0630.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders